Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)

SHA:688443 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,415	2,035	2,892	49.28	14.15	42.48
Trading Asset Securities	901.56	412.58	27.71	237.36	427.11	13.78
Cash & Short-Term Investments	2,316	2,448	2,920	286.64	441.25	56.27
Cash Growth	-9.55%	-16.16%	918.65%	-35.04%	684.19%	163.06%
Accounts Receivable	29.78	12.01	-	-	-	0.63
Other Receivables	3.67	1.38	0	-	1.53	3.66
Receivables	33.45	13.38	0	-	1.53	4.29
Inventory	73.9	50.15	55.45	56.33	33.66	15.85
Other Current Assets	98.83	110.59	56.56	56.03	52.76	30.38
Total Current Assets	2,522	2,622	3,032	399	529.2	106.79
Property, Plant & Equipment	458.09	441.55	487.82	487.75	327.83	267.8
Other Intangible Assets	42.73	43.59	43.54	45.08	45.92	48.94
Long-Term Deferred Charges	16.14	25.16	27.92	25.51	23.51	24.96
Other Long-Term Assets	5.66	13.26	3.46	4.77	76.36	49.68
Total Assets	3,045	3,146	3,595	962.11	1,003	498.17
Accounts Payable	95.13	67.06	83.04	67.84	46.61	33.31
Accrued Expenses	45.28	63.03	37.74	29.71	24.29	14.27
Short-Term Debt	-	-	0.63	-	-	-
Current Portion of Long-Term Debt	166.38	26.24	-	5.3	0.9	0.9
Current Portion of Leases	-	12.13	10.07	7.64	6.51	-
Other Current Liabilities	13.18	5.82	5.4	15.87	7.7	431.42
Total Current Liabilities	332.26	174.29	136.87	126.37	86.01	479.91
Long-Term Debt	872.88	786.13	608.48	738.59	535.55	349.66
Long-Term Leases	7.98	12.63	21.82	30.37	28.65	-
Long-Term Unearned Revenue	43.94	46.62	43.2	37.69	35.55	34.15
Other Long-Term Liabilities	-	-	-	-	5.08	9.51
Total Liabilities	1,257	1,020	810.36	933.03	690.84	873.22
Common Stock	366.68	366.68	366.68	275	275	200
Additional Paid-In Capital	4,192	4,192	4,038	573.29	279.82	249.98
Retained Earnings	-2,750	-2,418	-1,621	-819.21	-242.84	-825.04
Treasury Stock	-20.3	-14.67	-	-	-	-
Shareholders' Equity	1,788	2,126	2,784	29.08	311.98	-375.05
Total Liabilities & Equity	3,045	3,146	3,595	962.11	1,003	498.17
Total Debt	1,047	837.13	640.99	781.91	571.6	350.57
Net Cash (Debt)	1,269	1,611	2,279	-495.27	-130.35	-294.3
Net Cash Growth	-29.33%	-29.31%	-	-	-	-
Net Cash Per Share	3.46	4.38	7.11	-1.80	-0.47	-
Filing Date Shares Outstanding	366.68	366.68	366.68	275	275	-
Total Common Shares Outstanding	366.68	366.68	366.68	275	275	-
Working Capital	2,190	2,448	2,895	272.63	443.19	-373.12
Book Value Per Share	4.88	5.80	7.59	0.11	1.13	-
Tangible Book Value	1,745	2,082	2,741	-15.99	266.06	-423.99
Tangible Book Value Per Share	4.76	5.68	7.47	-0.06	0.97	-
Buildings	-	115.03	114.98	105.89	99.77	99.77
Machinery	-	516.53	457.63	302.65	261.93	214.75
Construction In Progress	-	6.74	52.18	164.82	18.27	9.32

Source: S&P Global Market Intelligence. Standard template. Financial Sources.